Editorial Team
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Editorial Team | Published : October 26, 2014 5:46 PM IST
A new target has been identified by scientists for the treatment of HIV. This has been possible by uncovering a crucial and previously unknown mechanism used in the cellular replication of the deadly virus.
Like a slumbering dragon, HIV can lay dormant in a person's cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.
Now, scientists at the Salk Institute for Biological Studies have uncovered a new protein that participates in active HIV replication.
The protein, called Ssu72, is part of a switch used to awaken HIV-1 (the most common type of HIV) from its slumber.
The team began by identifying a list of 50 or so proteins that interact with a well-known protein HIV creates called Tat.
'The virus cannot live without Tat," said Katherine Jones, Salk professor in the Regulatory Biology Laboratory and senior author of the study.
Tat acts as a lookout in the cell for the virus, telling the virus when the cellular environment is favourable for its replication.
When the environment is right, Tat kicks off the virus' transcription, the process by which HIV reads and replicates its building blocks (RNA) to spread throughout the body.
One of the proteins on the list that caught Jones' eye was Ssu72 (a phosphatase).
This enzyme had been shown in yeast to affect the transcription machinery. Her team found that Ssu72 binds directly to Tat and not only begins the transcription process, but also creates a feedback loop to ramp up the process.
'Tat is like an engine for HIV replication and Ssu72 revs up the engine,' said Lirong Zhang, one of the first authors.
'If we target this interaction between Ssu72 and Tat, we may be able to stop the replication of HIV,' said Zhang.
The team found that Ssu72 is not required for making RNA for most host cell genes in the way it is used by HIV, making it a potentially promising target for drug therapy.
'Many proteins that Tat interacts with are essential for normal cellular transcription so those can't be targeted unless you want to kill normal cells,' said co-first author Yupeng Chen, a Salk researcher.
'Ssu72 seems to be different - at least in the way it is used by HIV,' said Chen.
The study was published in the journal Genes and Development.
What is HIV?
The human immunodeficiency virus (HIV) is a retrovirus that destroys or impairs the function of the body's immune system making the person more susceptible to infections. Unless treated, it develops into full-blown acquired immunodeficiency syndrome (AIDS). The virus infects humans when it comes in contact with tissues lining the vagina, anal area, mouth and eyes, or through a break in the skin. There are two main types HIV-1 and HIV-2. HIV-2 is typically found in Africa and parts of Asia. HIV-2 is typically found in Africa and parts of Asia. Asia can thus no longer be considered free of HIV-2, and testing for HIV-2 appears mandatory, at least in India. Worldwide, when people refer to HIV they are usually referring to HIV-1.
With inputs from PTI
Photo source: Getty images
Follow us on Facebook and Twitter for all the latest updates! For daily free health tips, sign up for our newsletter.
